David Cheek

David Cheek

Auto-generated profile, based on publicly available information

David Cheek

Department of Genetics, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CMCameron S. McAlpine
Cameron S. McAlpine
MKMáté G. Kiss
Máté G. Kiss
FZFaris M. Zuraikat
Faris M. Zuraikat
DCDavid Cheek
David Cheek
GSGiulia Schiroli
Giulia Schiroli
FSFilip K. Swirski
Filip K. Swirski
A sleepless night may feel awful in its aftermath, but sleep’s revitalizing powers are substantial, perpetuating the idea that convalescent sleep is a consequence-free physiological reset. Although recent studies have shown that catch-up sleep insufficiently neutralizes the negative effects of sleep debt, the mechanisms that control prolonged effects of sleep disruption are not understood. Here, we show that sleep interruption restructures the epigenome of hematopoietic stem and progenitor cells (HSPCs) and increases their proliferation, thus reducing hematopoietic clonal diversity through accelerated genetic drift. Sleep fragmentation exerts a lasting influence on the HSPC epigenome, skewing commitment toward a myeloid fate and priming cells for exaggerated inflammatory bursts. Combining hematopoietic clonal tracking with mathematical modeling, we infer that sleep preserves clonal diversity by limiting neutral drift. In humans, sleep restriction alters the HSPC epigenome and activates hematopoiesis. These findings show that sleep slows decay of the hematopoietic system by calibrating the hematopoietic epigenome, constraining inflammatory output, and maintaining clonal diversity.

7 April 2023 in Journal of Mathematical Biology
Verified
Journal Article
Closed access
PDF file
DCDavid Cheek
David Cheek
SJSamuel G. G. Johnston
Samuel G. G. Johnston

5 April 2022 in Journal of Mathematical Biology
Verified
Journal Article
Open access
PDF file
DCDavid Cheek
David Cheek
We consider a class of density-dependent branching processes which generalises exponential, logistic and Gompertz growth. A population begins with a single individual, grows exponentially initially, and then growth may slow down as the population size moves towards a carrying capacity. At a time while the population is still growing superlinearly, a fixed number of individuals are sampled and their coalescent tree is drawn. Taking the sampling time and carrying capacity simultaneously to infinity, we prove convergence of the coalescent tree to a limiting tree which is in a sense universal over our class of models.

5 May 2026 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DCDavid Cheek
David Cheek
MBMartin Blohmer
Martin Blohmer
MNMartin A. Nowak
Martin A. Nowak
TATibor Antal
Tibor Antal
KNKamila Naxerova
Kamila Naxerova
Cancer-causing mutations have been identified primarily from positive selection signals in cancer genomes. However, positive selection is also a ubiquitous feature of normal tissue aging. Here we develop a statistical framework to disentangle selection in normal tissue and causation of carcinogenesis. By comparing cancer and normal tissue genomes, we estimate the effects of mutations on cancer risk in the blood, esophagus and colon. We determine that stronger cancer-causing mutations are enriched at younger patient ages. This enables cancer-causing mutations to be identified from patient age distributions, even without normal tissue data. Moreover, we show for acute myeloid leukemia that the age-dependence of purported causal mutations can be explained largely by normal blood evolution, challenging the long-standing notion that childhood cancers require distinct mutations. Broadly, our framework delineates carcinogenesis from normal tissue aging, improving the assessment of cancer risk conferred by mutations.

4 June 2020 in arXiv
Verified
Preprint
Open access
PDF file
DCDavid Cheek
David Cheek
TATibor Antal
Tibor Antal
We study a simple model of DNA evolution in a growing population of cells. Each cell contains a nucleotide sequence which randomly mutates at cell division. Cells divide according to a branching process. Following typical parameter values in bacteria and cancer cell populations, we take the mutation rate to zero and the final number of cells to infinity. We prove that almost every site (entry of the nucleotide sequence) is mutated in only a finite number of cells, and these numbers are independent across sites. However independence breaks down for the rare sites which are mutated in a positive fraction of the population. The model is free from the popular but disputed infinite sites assumption. Violations of the infinite sites assumption are widespread while their impact on mutation frequencies is negligible at the scale of population fractions. Some results are generalised to allow for cell death, selection, and site-specific mutation rates. For illustration we estimate mutation rates in a lung adenocarcinoma.

27 May 2022 in arXiv
Verified
Preprint
Open access
PDF file
DCDavid Cheek
David Cheek
SJSamuel G. G. Johnston
Samuel G. G. Johnston
Consider a branching process with a homogeneous reproduction law. Sampling a single cell uniformly from the population at a time $T > 0$ and looking along the sampled cell's ancestral lineage, we find that the reproduction law is heterogeneous - the expected reproductive output of ancestral cells on the lineage from time $0$ to time $T$ continuously increases. This `inspection paradox' is due to sampling bias, that cells with a larger number of offspring are more likely to have one of their descendants sampled by virtue of their prolificity, and the bias's strength grows with the random population size and/or the sampling time $T$. Our main result explicitly characterises the evolution of reproduction rates and sizes along the sampled ancestral lineage as a mixture of Poisson processes, which simplifies in special cases. The ancestral bias helps to explain recently observed variation in mutation rates along lineages of the developing human embryo.